CIK 0001566044
- Non-accelerated filer
- Smaller reporting company
Yarrow Bioscience, Inc.
Sign in to watch- Ticker
- YARW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453757789
- Phone
- +1 203-433-7577
- Business address
- 470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
- Former names
- VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
- 4 Shares withheld for taxes Chief Legal Officer and GC gave up 1,484 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 13,096 shares (to pay taxes)
- 4 Grant or award Interim CFO acquired 60,859 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 60,859 shares (grant or award)
- 4 Grant or award Chief Legal Officer and GC acquired 60,859 shares (grant or award)
- 4 Grant or award President and CEO acquired 320,312 shares (grant or award)
- 4 Open-market buy Director bought 12,500 shares at $1.60 ($20,000)
- 4 Open-market sale 10% owner sold 250,000 shares at $1.74 ($435,000)
- 4 Open-market sale 10% owner sold 250,000 shares at $1.84 ($460,000)
- 4 Open-market sale 10% owner sold 338,897 shares at $2.23 ($755,740)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Interim CFO gave up 700 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 5,151 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 3,083 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer and GC gave up 3,551 shares (to pay taxes)
Page 9 of 17 · 330 filings